This MedLibrary.org supplementary page on Fructosamine is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
Fructosamine is a compound that can be considered the result of a reaction between fructose and ammonia or an amine (with a molecule of water being released). A fructosamine is also formed when carbonyl group of glucose reacts with an amino group of a protein, as the double bond to oxygen moves from the end carbon atom to the next carbon atom and water is released. Fructosamines formed from blood proteins such as serum albumin are known as Glycated Serum Protein (GSP) or Glycated Albumin, and are used to identify the plasma glucose concentration over time and so assess diabetic control.[1]
| Diabetes mellitus
|
|---|
| Types of Diabetes |
| Diabetes mellitus type 1 Diabetes mellitus type 2 Gestational diabetes Pre-diabetes: |
| Disease Management |
| Diabetes management: •Diabetic diet •Anti-diabetic drugs •Conventional insulinotherapy •Intensive insulinotherapy |
| Other Concerns |
| Cardiovascular disease
Diabetic comas: Diabetic myonecrosis |
| Blood tests |
| Blood sugar Fructosamine Glucose tolerance test Glycosylated hemoglobin |
Contents |
Indications
Diabetics have their glucose control assessed with the Glycosylated hemoglobin measurement that assesses average glucose levels over the preceding 6 weeks, as reflected by the permanent glycosylation of a small fraction of the hemoglobin molecules in their blood. However, this is not appropriate where there has been a recent change in diet or treatment within 6 weeks, or if there are abnormalities of red blood cell aging or mix of hemoglobin subtypes (predominantly HbA in normal adults). Hence people with recent blood loss or hemolytic anemia, or hemoglobinopathy such as sickle-cell disease, are not suitable for some glycosylated hemoglobin methods that do not account for higher-turnover hemoglobin. Fructosamine is used in these circumstances, as it also reflects an average of blood glucose levels, but over a shorter period of 2 to 3 weeks. Fructosamine is also of use in conditions, such as pregnancy, in which hormonal changes cause greater short-term fluctuation in glucose concentrations.
Interpretation of results
There is no standard reference range available for this test. The reference values depends upon the factors of patient age, gender, sample population, and test method. Hence each laboratory reports will include their specific reference range for the test. An increase in fructosamine in lab testing results usually means an increase in glucose in the blood.
Approximately each change of 3.3 mmol (60 mg/dl) in average blood sugar levels will give rise to changes of 2% HbA1c and 75 µmol fructosamine values.[2] However this over emphasises the upper limit of many laboratories' reference ranges of 285mmol/l as equivalent to HbA1c 7.5% rather than 6.5%. A comparative study,[3] which has been used in official advice for Quality and Outcomes Framework guidance in the UK[4] and summaried by the United States' National Quality Measures Clearinghouse:[5] gives the following formula and resulting values:
- Hence:
| Fructosamine (µmol) |
HbA1c % |
|---|---|
| 200 | 5 |
| 258 | 6 |
| 288 | 6.5 |
| 317 | 7 |
| 346 | 7.5 |
| 375 | 8 |
| 435 | 9 |
| 494 | 10 |
| 552 | 11 |
| 611 | 12 |
See also
Footnotes
- ^ Delpierre G, Collard F, Fortpied J and Van Sschaftingen E (2002). "Fructosamine 3-kinase is involved in an intracellular deglycation pathway in human erythrocytes" (PDF). Biochem. J. 365: 801–8.
- ^ Bartol T (2000-12-01). "Comparison of Blood Glucose, HbA1c, and Fructosamine". Retrieved on 2007-06-04. - gives a comparison chart and cites following source:
- Nathan DM, Singer DE, Hurxthal K, Goodson JD (1984). "The clinical information value of the glycosylated hemoglobin assay". N. Engl. J. Med. 310 (6): 341–6. PMID 6690962.
- ^ Cohen RM, Holmes YR, Chenier TC, Joiner CH (2003). "Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy". Diabetes Care 26 (1): 163–7. PMID 12502674.
- ^ "Diabetes (DM) Indicator 20 The percentage of patients with diabetes in whom the last HbA1c is 7.5 or less (or equivalent test/reference range depending on local laboratory) in the previous 15 months", Quality and outcomes framework Guidance 2006 (PDF), BMA, 39. Retrieved on 2008-01-02.
- ^ "Diabetes mellitus: the percentage of patients with diabetes in whom the last HbA1c is 7.5 or less (or equivalent test/reference range depending on local laboratory) in the previous 15 months". National Quality Measures Clearinghouse (2007-12-31). Retrieved on 2008-01-02.
 |
This health-related article is a stub. You can help Wikipedia by expanding it. |
 |
This protein-related article is a stub. You can help Wikipedia by expanding it. |
Wikipedia content modification information:
- This page was last modified on 14 October 2008, at 01:06.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Fructosamine".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.